Гематология / лейкозы / лимфомы

<![CDATA[Where Do CELMoDs Fit With CAR T Cells and Bispecifics in Multiple Myeloma?]]>

Three-drug treatment regimen shows promise for difficult-to-treat brain lymphoma

A collaborative clinical study led by National Taiwan University Hospital (NTUH) and Taiwan Clinical Oncology Group, National Health Research Institutes (TCOG, NHRI) has yielded promising results for a new therapeutic regimen to treat primary central nervous system lymphoma (PCNSL), a rare and aggressive cancer that…

<![CDATA[CELMoD Wins “Landmark Approval” in Relapsed/Refractory Multiple Myeloma]]>

<![CDATA[Debate: Class Effect Versus Meaningful Differences Among BCMA Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma]]>

<![CDATA[Debate: CAR-T Cell Therapy Versus BCMA Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma]]>

Acute myeloid leukemia increasingly impacting older adults globally

Acute myeloid leukemia (AML) poses an increasing global burden for older adults, according to a study published online Aug. 19 in the Journal of Geriatric Oncology.

<![CDATA[Preparing for Advanced Therapy in Relapsed/Refractory Multiple Myeloma]]>

<![CDATA[Evolving Treatment Goals in Relapsed/Refractory Multiple Myeloma]]>

<![CDATA[Long-Term Hodgkin Lymphoma Survivors Show Nearly 2-Fold Mortality Increase]]>

<![CDATA[Teclistamab Combo Earns EU Approval in Relapsed/Refractory Multiple Myeloma]]>